Article
Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer
12 Oct 2012
Abstract excerpt
Oncolytic virus (OV) therapy is an emerging anti-cancer approach that utilizes viruses to preferentially infect and kill cancer cells, while not harming healthy cells. Vesicular stomatitis virus (VSV) is a prototypic non-segmented, negative-strand RNA virus with inherent OV qualities. Antiviral responses induced by type I interferon pathways are believed to be impaired in most cancer cells, making them more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
